FOXO3 and cancer: These findings highlight that FOXM1 overactivation or FOXO3 inhibition can drive the expression of DNA damage response genes to increase repair or tolerance to DNA damage induced by genotoxic agents and thereby, contribute to the ability of cancer cells to survive the genotoxic function of anticancer drug.